查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1786412

全球糖尿病護理設備市場

Diabetes Care Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 282 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球糖尿病護理設備市場規模將達 869 億美元

全球糖尿病護理設備市場規模預計在2024年達到482億美元，預計在分析期（2024-2030年）內將以10.3%的複合年成長率成長，到2030年將達到869億美元。血糖監測設備是本報告分析的細分市場之一，預計其複合年成長率將達到12.5%，到分析期末將達到511億美元。胰島素給藥設備細分市場在分析期間的複合年成長率預計為7.7%。

美國市場規模估計為 131 億美元，中國市場預計複合年成長率為 14.4%

美國糖尿病護理設備市場規模預計2024年達到131億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到182億美元，在2024-2030年的分析期間內，複合年成長率為14.4%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為7.2%和9.2%。在歐洲，預計德國市場的複合年成長率約為8.2%。

全球糖尿病護理設備市場—主要趨勢與促進因素摘要

糖尿病照護設備的進步如何改善病患的治療效果？

糖尿病護理設備市場正經歷一場革命性的變革，這得益於技術創新，這些創新改善了疾病的監測、管理和治療依從性。持續血糖監測 (CGM) 系統的發展帶來了翻天覆地的變化，它能夠即時洞察血糖值波動，減少對傳統指尖採血檢測的依賴。此外，智慧胰島素筆和閉合迴路胰島素幫浦等胰島素輸送系統也讓糖尿病管理更加精準便利。數位健康融合的興起進一步增強了遠端監控能力，使醫療服務提供者能夠根據即時數據制定個人化治療方案。此外，全球糖尿病盛行率不斷上升，尤其是在發展中地區，這刺激了對價格實惠且易於使用的糖尿病護理設備的需求。目前，各公司正專注於小型化和非侵入性技術，以使設備更易於患者使用，並減少對患者的侵入性。

哪些突破性創新將改變糖尿病管理？

糖尿病護理設備領域的最新創新浪潮聚焦於自動化、人工智慧主導的分析和非侵入性監測。人工胰臟系統能夠根據持續血糖測量自動調節胰島素輸送，正在徹底改變糖尿病管理。穿戴式和植入式感測器正逐漸成為傳統動態血糖監測（CGM）的有力替代品，它們能夠提高準確性並延長佩戴時間。採用微針技術的智慧型貼片也因其無痛血糖監測而日益普及。另一項重大進展是人工智慧主導的預測分析技術的整合，它可以檢測血糖模式並幫助提前預測血糖波動。此外，生物感測器技術的進步正在消除侵入性採血的需求，為汗液式血糖監測鋪路。這些技術創新正在使糖尿病管理更加高效，減輕患者的負擔。

數位健康如何重塑糖尿病照護生態系統？

包括行動應用程式、雲端基礎平台和遠端醫療在內的數位健康解決方案的整合正在徹底改變糖尿病管理。連接智慧型手機的血糖監測儀允許用戶追蹤測量結果、接收即時警報並與醫療保健提供者無縫共用數據。此外，人工智慧糖尿病指導應用程式的普及使患者能夠獲得個人化的飲食和生活方式建議。遠端患者監護計畫的興起進一步加強了慢性病管理，尤其是在服務不足、無法獲得內分泌科醫師服務的社區。保險公司和雇主也擴大採用整合了促進主動照護的數位工具的糖尿病管理計畫。這些發展顯著提高了患者參與度和長期疾病管理。

糖尿病護理設備市場成長的主要驅動力是什麼？

糖尿病護理設備市場的成長受到多種因素的推動，包括糖尿病盛行率的上升、對微創監測解決方案的需求不斷成長以及數位健康技術的日益普及。人工胰臟系統和先進胰島素輸送設備的擴展顯著改善了患者的治療效果，推動了市場的成長。此外，生物感測器技術的不斷創新使血糖監測更加準確和方便用戶使用。人工智慧在糖尿病管理中的日益普及也在預測和預防併發症方面發揮關鍵作用。此外，政府為提高糖尿病意識和改善治療機會的措施正在進一步加速市場擴張。穿戴式遠端醫療解決方案的迅速普及正在加強疾病監測和治療依從性，進一步推動成長。在持續的技術進步和日益以患者為中心的方法的推動下，糖尿病護理設備市場預計將在未來幾年持續擴張。

部分

產品類型（血糖監測設備、胰島素輸送設備）、最終用途（醫院、門診手術中心、診斷中心、居家照護、其他）

受訪公司範例

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • ARKRAY, Inc.
  • Ascensia Diabetes Care Holdings AG
  • DarioHealth Corp.
  • Dexcom, Inc.
  • Diabeloop SA
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • Glenmark Pharmaceuticals Ltd.
  • GlucoMe
  • iHealth Labs, Inc.
  • Integrated Diabetes Services, LLC
  • Medtronic Plc
  • Novo Nordisk A/S
  • Prodigy Diabetes Care, LLC
  • Tandem Diabetes Care, Inc.
  • Trividia Health, Inc.
  • Ypsomed AG

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 沒有遵循典型的 LLM 或特定於行業的 SLM查詢，而是建立了一個從世界各地的專家收集的內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP30461

Global Diabetes Care Devices Market to Reach US$86.9 Billion by 2030

The global market for Diabetes Care Devices estimated at US$48.2 Billion in the year 2024, is expected to reach US$86.9 Billion by 2030, growing at a CAGR of 10.3% over the analysis period 2024-2030. Blood Glucose Monitoring Devices, one of the segments analyzed in the report, is expected to record a 12.5% CAGR and reach US$51.1 Billion by the end of the analysis period. Growth in the Insulin Delivery Devices segment is estimated at 7.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$13.1 Billion While China is Forecast to Grow at 14.4% CAGR

The Diabetes Care Devices market in the U.S. is estimated at US$13.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$18.2 Billion by the year 2030 trailing a CAGR of 14.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.2% and 9.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.2% CAGR.

Global Diabetes Care Devices Market - Key Trends & Drivers Summarized

How Are Advancements in Diabetes Care Devices Enhancing Patient Outcomes?

The diabetes care devices market is undergoing a revolutionary shift, driven by technological innovations that are improving disease monitoring, management, and treatment adherence. The development of continuous glucose monitoring (CGM) systems has been a game-changer, providing real-time insights into blood sugar fluctuations and reducing dependence on traditional fingerstick testing. Additionally, insulin delivery systems, such as smart insulin pens and closed-loop insulin pumps, are making diabetes management more precise and convenient. The rise of digital health integration has further enhanced remote monitoring capabilities, allowing healthcare providers to personalize treatment plans based on real-time data. Moreover, the increasing prevalence of diabetes worldwide, particularly in developing regions, has spurred the demand for affordable and user-friendly diabetes care devices. Companies are now focusing on miniaturization and non-invasive technologies to make devices more accessible and less cumbersome for patients.

What Are the Breakthrough Innovations Transforming Diabetes Management?

The latest wave of innovations in diabetes care devices is centered around automation, AI-driven analytics, and non-invasive monitoring. Artificial pancreas systems, which automatically adjust insulin delivery based on continuous glucose readings, are revolutionizing diabetes control. Wearable and implantable sensors are emerging as promising alternatives to traditional CGMs, offering improved accuracy and longer wear durations. Smart patches with microneedle technology are also gaining traction for pain-free glucose monitoring. Another key development is the integration of AI-driven predictive analytics, which helps detect patterns and anticipate glucose fluctuations before they occur. Additionally, advances in biosensor technology are paving the way for glucose monitoring through sweat and tears, eliminating the need for invasive blood sampling. With these innovations, diabetes management is becoming more efficient and less intrusive for patients.

How Is Digital Health Reshaping the Diabetes Care Ecosystem?

The integration of digital health solutions, including mobile apps, cloud-based platforms, and telemedicine, is revolutionizing diabetes management. Smartphone-connected glucose monitors allow users to track their readings, receive real-time alerts, and share data with healthcare providers seamlessly. The proliferation of AI-driven diabetes coaching apps is also empowering patients with personalized dietary and lifestyle recommendations. The rise of remote patient monitoring programs has further strengthened chronic disease management, especially in underserved regions where access to endocrinologists is limited. Insurance companies and employers are also increasingly adopting diabetes management programs that integrate digital tools to promote proactive care. These developments are significantly enhancing patient engagement and long-term disease control.

What Are the Key Drivers Behind the Expansion of the Diabetes Care Devices Market?

The growth in the diabetes care devices market is driven by several factors, including rising diabetes prevalence, growing demand for minimally invasive monitoring solutions, and increasing adoption of digital health technologies. The expansion of artificial pancreas systems and advanced insulin delivery devices is significantly improving patient outcomes, fueling market growth. Additionally, continuous innovations in biosensor technology are making glucose monitoring more accurate and user-friendly. The increasing penetration of AI in diabetes management is also playing a pivotal role in predicting and preventing complications. Moreover, government initiatives to promote diabetes awareness and improve access to care are further accelerating market expansion. The rapid uptake of wearable health technologies and telehealth solutions is enhancing disease monitoring and treatment adherence, propelling further growth. With the ongoing technological advancements and growing patient-centric approaches, the diabetes care devices market is expected to witness sustained expansion in the coming years.

SCOPE OF STUDY:

The report analyzes the Diabetes Care Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Blood Glucose Monitoring Devices, Insulin Delivery Devices); End-Use (Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • ARKRAY, Inc.
  • Ascensia Diabetes Care Holdings AG
  • DarioHealth Corp.
  • Dexcom, Inc.
  • Diabeloop SA
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • Glenmark Pharmaceuticals Ltd.
  • GlucoMe
  • iHealth Labs, Inc.
  • Integrated Diabetes Services, LLC
  • Medtronic Plc
  • Novo Nordisk A/S
  • Prodigy Diabetes Care, LLC
  • Tandem Diabetes Care, Inc.
  • Trividia Health, Inc.
  • Ypsomed AG

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Diabetes Care Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Diabetes Prevalence Throws the Spotlight on Technology-Driven Diabetes Care Devices
    • Shift Toward Personalized, Data-Driven Disease Management Spurs Demand for Smart Glucose Monitoring Systems
    • Rapid Adoption of Continuous Glucose Monitoring (CGM) Devices Strengthens the Business Case for Non-Invasive Solutions
    • Integration of Diabetes Devices with Smartphones and Wearables Enhances Real-Time Data Sharing and Engagement
    • Growth in Closed-Loop Systems and Artificial Pancreas Devices Accelerates Innovation in Insulin Delivery
    • Increased Use of Connected Insulin Pens and Smart Dose Calculators Promotes Adherence and Accuracy
    • Demand for Minimally Invasive and Painless Monitoring Technologies Drives Market Differentiation
    • Government Initiatives for Diabetes Prevention and Management Support Widespread Device Reimbursement
    • Rising Incidence of Type 1 Diabetes in Children Fuels Demand for Pediatric-Friendly Monitoring Systems
    • Digital Therapeutics and Remote Patient Monitoring Platforms Enhance Device Interoperability
    • Expansion of At-Home Testing and DTC Models Broadens Access to Personalized Diabetes Tools
    • Growing Popularity of Subscription Models and Integrated Care Platforms Drives Device Retention
    • Clinical Preference for Integrated Data Platforms Supports Multi-Device Ecosystem Development
    • AI-Driven Insights and Predictive Analytics Expand the Role of Devices in Proactive Disease Management
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Diabetes Care Devices Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Diabetes Care Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Diabetes Care Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Diabetes Care Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Blood Glucose Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Blood Glucose Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Insulin Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Insulin Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Insulin Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospital End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospital End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospital End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgical Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Surgical Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Ambulatory Surgical Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Homecare End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Homecare End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Homecare End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Diabetes Care Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Diabetes Care Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Diabetes Care Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Diabetes Care Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Diabetes Care Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Diabetes Care Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Diabetes Care Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Diabetes Care Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Diabetes Care Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Diabetes Care Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Diabetes Care Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Care Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Diabetes Care Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Diabetes Care Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Diabetes Care Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Diabetes Care Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Diabetes Care Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Diabetes Care Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Diabetes Care Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Diabetes Care Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Diabetes Care Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Diabetes Care Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Diabetes Care Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Diabetes Care Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Diabetes Care Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Diabetes Care Devices by Product Type - Blood Glucose Monitoring Devices and Insulin Delivery Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Diabetes Care Devices by Product Type - Percentage Breakdown of Value Sales for Blood Glucose Monitoring Devices and Insulin Delivery Devices for the Years 2015, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Diabetes Care Devices by End-Use - Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Diabetes Care Devices by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgical Centers End-Use, Diagnostic Centers End-Use, Homecare End-Use and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION